GlassScriptPhysician profile
Thomas S Metkus
NPI 1619947116
$12,857.96
in general payments reported to CMS, 2019-2025
28 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.91 · 2021: $314 · 2022: $729 · 2023: $703 · 2024: $532 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $1,734.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $10,000.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $814.20 | 2021-2025 | |
| Medtronic, INC. | $273.53 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Impulse Dynamics (USA) INC. | $209.60 | 2022-2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $166.56 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.48 | 2021-2025 | Lifevest |
| Pfizer INC. | $154.90 | 2022-2024 | |
| Teleflex LLC | $132.07 | 2023 | Arrow |
| Boston Scientific Corporation | $115.49 | 2022-2025 | Bodyguardian, Watchman Access System |
| Getinge USA Sales, LLC | $96.14 | 2024 | Base Unit Servo-U |
| Merck Sharp & Dohme LLC | $95.25 | 2021-2025 | Verquvo |
| Philips North America LLC | $82.94 | 2022-2023 | |
| Biotronik INC. | $58.56 | 2021 | |
| Lantheus Medical Imaging, INC. | $54.51 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $54.10 | 2019-2023 | Eliquis |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.81 | 2022-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $47.99 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $47.61 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $40.03 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abiomed | $30.36 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $29.53 | 2024 | |
| Angiodynamics, INC. | $23.32 | 2021 | |
| Alnylam Pharmaceuticals INC. | $22.12 | 2025 | Onpattro |
| Edwards Lifesciences Corporation | $20.18 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $18.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.34 | 2023 | Xarelto |
| Heartflow, INC. | $18.18 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $16.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Metkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.